Central Trust Company’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19
Closed 1369
2022
Q2
$0 Hold
19
﹤0.01% 1419
2022
Q1
$0 Buy
+19
New +$465 ﹤0.01% 1431
2020
Q1
Sell
-24
Closed 1187
2019
Q4
$0 Hold
24
﹤0.01% 1198
2019
Q3
$0 Hold
24
﹤0.01% 1171
2019
Q2
$0 Hold
24
﹤0.01% 1162
2019
Q1
$0 Hold
24
﹤0.01% 1127
2018
Q4
$0 Sell
24
-52
-68% -$2.09K ﹤0.01% 1205
2018
Q3
$4K Hold
76
﹤0.01% 1145
2018
Q2
$3K Sell
76
-68
-47% -$3.26K ﹤0.01% 1162
2018
Q1
$8K Hold
144
﹤0.01% 1042
2017
Q4
$8K Buy
144
+30
+26% +$1.42K ﹤0.01% 1016
2017
Q3
$5K Buy
114
+38
+50% +$1.81K ﹤0.01% 1049
2017
Q2
$5K Sell
76
-2
-3% -$119 ﹤0.01% 1050
2017
Q1
$5K Buy
78
+2
+3% +$139 ﹤0.01% 1038
2016
Q4
$5K Hold
76
﹤0.01% 1076
2016
Q3
$5K Buy
+76
New +$5.2K ﹤0.01% 1026
2014
Q4
Sell
-62
Closed -$3K 1211
2014
Q3
$3K Hold
62
﹤0.01% 1121
2014
Q2
$4K Hold
62
﹤0.01% 1083
2014
Q1
$4K Buy
+62
New +$3.61K ﹤0.01% 1091

Other funds holding MD

Central Trust Company's MD Position: Q3 2022 in Review

Central Trust Company sold out of Pediatrix Medical (MD) in Q3 2022, closing a stake of 19 shares.

Central Trust Company first reported a position in MD in Q1 2014 and held it in 19 quarters. The position peaked at $8K in Q1 2018. 211 funds tracked by Wall St. Rank hold MD as of Q3 2022.

  • Central Trust Company reported no remaining Pediatrix Medical position as of Q3 2022 after selling out during the quarter.
  • Central Trust Company sold 19 Pediatrix Medical shares in Q3 2022.
  • Central Trust Company first reported a position in Pediatrix Medical in Q1 2014 and held it in 19 quarters.
  • Central Trust Company's Pediatrix Medical position peaked at $8K in Q1 2018.
  • 211 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2022.

Based on Central Trust Company's 13F filing for Q3 2022, filed 3 Nov 2022.